- Abstract Number: 0500
Genomic, Phenomic, Proteomic Predictors of Psoriatic Arthritis
- Abstract Number: 2037
Geographic Distribution and Environmental Triggers of Systemic Sclerosis in Massachusetts
- Abstract Number: 0086
Geographic Distribution of Eosinophilic Fasciitis Cases in Massachusetts and Associated Environmental Triggers
- Abstract Number: 0043
Geographical Disparity in Rheumatoid Arthritis Disease Burden Independent of Race/Ethnicity
- Abstract Number: 0005
Geographical Variations in COVID-19 Perceptions and Patient Management: A National Survey of Rheumatologists
- Abstract Number: 0238
Gestational Desire and Certolizumab Pegol in Patients with Chronic Inflammatory Rheumatic Disease. Preliminary Results of the GESTAMAD Cohort
- Abstract Number: 1257
Gestational Diabetes Mellitus in Pregnant Women with Systemic Lupus Erythematosus
- Abstract Number: 1932
Giant Cell Arteritis – the Relationship Between the Extensiveness of Vasculitis and the Clinical Presentation
- Abstract Number: 1077
Glucagon-like Peptide-1 Receptor Agonist Suppresses Muscle Inflammation and Muscle Fiber Death, and Ameliorates Muscle Weakness in Experimental Polymyositis
- Abstract Number: 1224
Glucocorticoid Reduction in Different Profiles of Patients with Rheumatoid Arthritis and Treatment with Sarilumab
- Abstract Number: 0129
Glucocorticoid-Induced Osteoporosis in Patients with Chronic Inflammatory Rheumatic Diseases: A Multivariate Linear Regression Analysis Identifying Factors Affecting Bone Mineral Density
- Abstract Number: 0109
Glucocorticoid-Induced Osteoporosis: Are We Practicing Prevention?
- Abstract Number: 1682
Goal-Setting Improves Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus
- Abstract Number: 0578
Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics
- Abstract Number: 0657
Gout and Heart Failure in the US
- « Previous Page
- 1
- …
- 52
- 53
- 54
- 55
- 56
- …
- 139
- Next Page »